GlassScriptPhysician profile
Kayla Rice
NPI 1558994772
$1,750.69
in general payments reported to CMS, 2019-2025
22 companies · $693 in 2025
The $693 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $138 · 2023: $293 · 2024: $409 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197 · Education: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.49 |
| Education | $198.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $375.95 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $295.09 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $190.04 | 2021-2024 | Aveed, Xiaflex |
| Boston Scientific Corporation | $117.19 | 2021 | |
| 180 Medical, INC. | $113.84 | 2023-2025 | Gentlecath, Gentlecath Glide, Cure Catheter |
| Urovant Sciences INC | $83.42 | 2021-2022 | |
| Abbvie INC. | $81.06 | 2023-2024 | |
| Procept Biorobotics Corporation | $80.54 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Exact Sciences Corporation | $69.86 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Exeltis, USA INC. | $44.32 | 2025 | Slynd |
| Sage Therapeutics, LLC | $42.22 | 2025 | Zurzuvae |
| Tolmar, INC. | $40.13 | 2023-2024 | |
| Antares Pharma, INC. | $28.50 | 2022 | |
| Hologic Sales and Service, LLC | $25.10 | 2025 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $24.59 | 2023 | Lynparza, Keytruda |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $24.56 | 2023 | |
| Fresenius Kabi USA, LLC | $23.76 | 2025 | |
| Coloplast Corp | $21.12 | 2024 | |
| Organon LLC | $20.81 | 2025 | Nexplanon |
| Supernus Pharmaceuticals, INC. | $19.66 | 2025 | Xyosted, Qelbree |
| Amgen INC. | $15.93 | 2024 | Prolia, Evenity |
| Myovant Sciences INC. | $13.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.